Balchem Co. (NASDAQ:BCPC) Shares Sold by Nuveen Asset Management LLC

Nuveen Asset Management LLC lessened its holdings in Balchem Co. (NASDAQ:BCPC - Free Report) by 6.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 194,008 shares of the basic materials company's stock after selling 12,329 shares during the quarter. Nuveen Asset Management LLC owned approximately 0.60% of Balchem worth $31,622,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Congress Asset Management Co. increased its holdings in Balchem by 5.4% in the fourth quarter. Congress Asset Management Co. now owns 317,610 shares of the basic materials company's stock valued at $51,769,000 after buying an additional 16,170 shares during the last quarter. Apollon Wealth Management LLC acquired a new position in Balchem in the fourth quarter valued at $503,000. Charles Schwab Investment Management Inc. boosted its stake in Balchem by 2.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 370,912 shares of the basic materials company's stock valued at $60,457,000 after acquiring an additional 8,942 shares in the last quarter. Tributary Capital Management LLC boosted its stake in Balchem by 1.2% in the fourth quarter. Tributary Capital Management LLC now owns 136,255 shares of the basic materials company's stock valued at $22,209,000 after acquiring an additional 1,634 shares in the last quarter. Finally, Victory Capital Management Inc. boosted its stake in Balchem by 25.9% in the fourth quarter. Victory Capital Management Inc. now owns 124,413 shares of the basic materials company's stock valued at $20,279,000 after acquiring an additional 25,560 shares in the last quarter. Hedge funds and other institutional investors own 87.91% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on BCPC. Wall Street Zen downgraded shares of Balchem from a "buy" rating to a "hold" rating in a research note on Wednesday, May 21st. HC Wainwright set a $180.00 price objective on shares of Balchem and gave the company a "buy" rating in a research note on Monday, April 28th. Finally, Sidoti upgraded shares of Balchem to a "hold" rating in a research note on Tuesday, February 25th.

Balchem Stock Performance

NASDAQ BCPC traded up $3.06 during trading hours on Tuesday, hitting $169.02. The company had a trading volume of 251,116 shares, compared to its average volume of 137,908. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.99. Balchem Co. has a 1-year low of $145.70 and a 1-year high of $186.03. The company has a market cap of $5.51 billion, a PE ratio of 43.01, a price-to-earnings-growth ratio of 4.41 and a beta of 0.93. The business has a 50 day moving average of $161.93 and a 200-day moving average of $166.01.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing the consensus estimate of $1.25 by ($0.03). Balchem had a return on equity of 11.37% and a net margin of 13.47%. The business had revenue of $250.52 million for the quarter, compared to analyst estimates of $245.70 million. During the same quarter last year, the company posted $1.03 EPS. Balchem's quarterly revenue was up 4.5% on a year-over-year basis. As a group, equities research analysts expect that Balchem Co. will post 4.64 EPS for the current year.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.